Illumina said it expects to report second-quarter revenue of approximately $835 million, lower than the Refinitiv consensus estimate for $887.9 million in revenue. Illumina said it now expects revenue to grow about 6% this fiscal year.
That’s far below its previous projection for about 13% to 14% revenue growth in fiscal 2019.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,